STOCK TITAN

Strata Critical Medical Inc Stock Price, News & Analysis

SRTA Nasdaq

Welcome to our dedicated page for Strata Critical Medical news (Ticker: SRTA), a resource for investors and traders seeking the latest updates and insights on Strata Critical Medical stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Strata Critical Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Strata Critical Medical's position in the market.

Rhea-AI Summary

Strata Critical Medical (Nasdaq: SRTA) will release third quarter financial results for the period ended September 30, 2025 on Monday, November 10, 2025 before market open and will host a conference call the same day at 8:00 AM Eastern Time.

The call will be led by Co-CEOs Melissa Tomkiel and Will Heyburn and will include a Q&A. Participants must register to receive dial-in details and a unique PIN. An audio-only webcast will be available via the company’s Investors site and a replay will be available for one year.

Business description: Strata provides time-critical air and ground logistics, surgical organ recovery, organ placement, normothermic regional perfusion, and perfusion staffing and equipment solutions under the Trinity Medical Solutions and Keystone Perfusion brands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
conferences earnings
-
News
Rhea-AI Summary

Strata Critical Medical (NASDAQ:SRTA), formerly Blade Air Mobility (NASDAQ:BLDE), has announced its upcoming Investor Day scheduled for November 17th, 2025 at the Nasdaq MarketSite in New York City. The event will commence at 2:00 PM ET and will feature presentations from the company's management team.

Interested investors and analysts can register for the event through Strata's Investor Relations website. A live video webcast and presentation materials will be accessible at ir.stratacrtical.com on the day of the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.98%
Tags
none
-
Rhea-AI Summary

Strata Critical Medical (NASDAQ:SRTA) has completed the acquisition of Keystone Perfusion Services LLC for $124 million, representing a 9x multiple of 2025 estimated Adjusted EBITDA. The acquisition combines Strata's existing capabilities with Keystone's expertise in organ recovery and normothermic regional perfusion services.

Keystone is projected to generate $65 million in revenue and $13 million in Adjusted EBITDA for 2025, with revenue growth exceeding 50% compared to 2024. The deal structure includes 88% cash and 12% stock consideration, with potential earn-outs of up to $23 million based on performance through 2028.

Following the acquisition, Strata has updated its 2025 guidance to $180-190 million in revenue and $13-14 million in Adjusted EBITDA. If the acquisition had closed on January 1, 2025, the projected figures would be $225-235 million in revenue and $22-24 million in Adjusted EBITDA.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.17%
Tags
Rhea-AI Summary

Strata Critical Medical (NASDAQ:SRTA), previously Blade Air Mobility (NASDAQ:BLDE), has announced its participation in the upcoming 2025 Jefferies Industrials Conference. The company's Co-CEO and CFO, Will Heyburn, will deliver a presentation on September 4, 2025, at 11:30 AM ET.

Investors can access the presentation via webcast, with a replay available afterward on the company's investor relations website at ir.stratacritical.com/news-events.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Strata Critical Medical (NASDAQ:SRTA), formerly Blade Air Mobility (NASDAQ:BLDE), has completed the sale of its Passenger business to Joby Aviation (NYSE:JOBY). The transaction includes stock-based upfront payment, with potential additional consideration of up to $35 million tied to employee retention and financial performance targets, plus up to $10 million in indemnity holdbacks.

The company has rebranded to focus exclusively on organ logistics and medical services, leveraging its coast-to-coast asset-light aircraft network. For FY2025, Strata projects revenue of $160-170 million with double-digit Adjusted EBITDA, and expects quarterly corporate expenses to decrease to $3.5 million by Q4 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Strata Critical Medical (SRTA)?

The current stock price of Strata Critical Medical (SRTA) is $5.57 as of October 14, 2025.

What is the market cap of Strata Critical Medical (SRTA)?

The market cap of Strata Critical Medical (SRTA) is approximately 418.8M.
Strata Critical Medical Inc

Nasdaq:SRTA

SRTA Rankings

SRTA Stock Data

418.84M
68.01M
11.06%
75.52%
2.98%
Airports & Air Services
Air Transportation, Nonscheduled
Link
United States
NEW YORK